Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of CA125 and HE4 Assays to Estimate the Risk of Ovarian Cancer in Patients Presenting to a General Surgeon or Obstetrician/Gynecologist With an Adnexal Mass

NCT00987649 is registered in ClinicalTrials.gov with Fujirebio Diagnostics, Inc. as lead sponsor.

NCT NCT00987649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of CA125 and HE4 Assays to Estimate the Risk of Ovarian Cancer in Patients Presenting to a General Surgeon or Obstetrician/Gynecologist With an Adnexal Mass
Lead sponsor
Fujirebio Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
September 30, 2010
Enrollment
512 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

adnexal mass, ovarian cancer